Deutsche Bank continues prime brokerage expansion

Jonathan Rose joins as head of West Coast global prime finance sales. Rose will be based in San Francisco and report to Chris Sharp, a director at Deutsche Bank. Rose was previously an executive director in prime brokerage sales at Morgan Stanley, also in San Francisco.

Kevin Harrison will join Deutsche’s global prime finance business as head of financing in the global markets division, responsible for managing equity financing. He joins from Bear Stearns, where he was a senior managing director in equity financing in the prime brokerage group.

Harrison will be based in New York and report to Jeff Dorman, head of global prime finance North America, who will start in this role later in May.

Sean Capstick and Danny Caplan have been appointed co-heads of prime finance sales in Europe, with Capstick also becoming head of the hedge fund capital group for Europe. They will be based in London and will report to Jason Good, head of equity sales for Europe.

Capstick will also report to John Dyment, head of the hedge fund capital group. He joins from Morgan Stanley, where he was responsible for prime brokerage sales in the UK.

Caplan was previously responsible for Deutsche Bank’s prime finance sales in Europe. He will take on responsibility for structuring products for European prime brokerage clients.

Maarten Nederlof has joined Deutsche Bank’s hedge fund capital group. He will develop structured products for institutional customers. He will be based in New York and report to John Dyment, the group’s head. Nederlof was previously a portfolio manager at K2 Advisors, a Stamford, Connecticut-based fund of hedge funds manager.

The expansion began in January with the appointment of Barry Bausano and Jonathan Hitchon as co-heads of global prime finance and the subsequent hire of Jeff Dorman as head of global prime finance in North America. (See Deutsche hires to expand prime brokerage and Deutsche Bank bolsters equity prime brokerage)

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here